CSI Market
Sign In | Register

Vaxart Inc (VXRT) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access VXRT quarterly Cash Flow →
Cash flow data covering Vaxart Inc–Dec 31 2021 offers a view into how Dec 31 2025's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income16.33
Depreciation & amortization8.58
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.04
Share-based Compensation8.31
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest-
Gain Recorded On Merger-
Noncash Royalty Revenue Related To Sale Of Future Royalties-
Amortization Of Discount On Shortterm Investments-
Lossgain On Revaluation Of Financial Instruments-
Impairment Of Intangible Assets Excluding Goodwill-
Noncash Interest Expense Related To Sale Of Future Royalties-
Gain Loss On Merger-
Noncash Interest Expense On Liability2.82
Increase Decrease In Unbilled Receivable-30.57
Investment Income Net Amortization Of Discount And Premium-0.28
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-8.80
Increase (Decrease) in Accounts Payable14.64
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities33.74
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets18.80
Other Working Capital0.00
Other Noncash Expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-55.88
Discontinued operations0.00
Net Cash flow from Operating Activities7.71
Investing Activities
Capital Expenditures-0.15
Sale of Capital Items0.01
Proceeds from Maturities, Prepayments and Calls of Short-term Investments40.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Cash Acquired In Reverse Merger-
Payments Forfractionalsharesinmerger-
Payments For Rightofuse Assets-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments-23.23
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities16.63
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net4.06
Proceeds From Sale Of Future Royalties Net-
Net Proceeds From Issuance Of Common Stock Pre Funded Warrants And Common Warrants In Underwritten Offering-
Proceeds From Disgorgement Of Shortswing Profits Net Of Costs-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Issuance Of Warrants To Placement Agents Designees-
Noncash Or Part Noncash Acquisition Value Of Assets Acquired-
Proceeds From Stock Plans Treasury Stock0.18
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities4.24
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow7.57
Total Cash Flow28.59
4 historic quarters locked

Sign in to unlock the full Vaxart Inc cash flow history.

Sign In Create Free Account

About Vaxart Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-26-008023

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License